{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:26:15Z","timestamp":1788395175414,"version":"build-2803163510"},"reference-count":61,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Drug-induced long QT syndrome can be a very dangerous side effect of existing and developmental drugs. In this work, a model proposed two decades ago addressing the ion specificity of potassium channels is extended to the human ether-\u00e0-gogo gene (hERG). hERG encodes the protein that assembles into the potassium channel responsible for the delayed rectifier current in ventricular cardiac myocytes that is often targeted by drugs associated with QT prolongation. The predictive value of this model can guide a rational drug design decision early in the drug development process and enhance NCE (New Chemical Entity) retention. Small molecule drugs containing a nitrogen that can be protonated to afford a formal +1 charge can interact with hERG to prevent the repolarization of outward rectifier currents. Low-level ab initio calculations are employed to generate electronic features of the drug molecules that are known to interact with hERG. These calculations were employed to generate structure\u2013activity relationships (SAR) that predict whether a small molecule drug containing a protonated nitrogen has the potential to interact with and inhibit the activity of the hERG potassium channels of the heart. The model of the mechanism underlying the ion specificity of potassium channels offers predictive value toward optimizing drug design and, therefore, minimizes the effort and expense invested in compounds with the potential for life-threatening inhibitory activity of the hERG potassium channel.<\/jats:p>","DOI":"10.3390\/ijms231810732","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T23:16:36Z","timestamp":1663197396000},"page":"10732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["New Insights into Ion Channels: Predicting hERG-Drug Interactions"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8157-5281","authenticated-orcid":false,"given":"Michael Fitzpatrick","family":"Wempe","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado\u2014Anschutz Medical Campus, Aurora, CO 80045, USA"},{"name":"University of Colorado Cancer Center, University of Colorado\u2014Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-2860(00)00774-2","article-title":"Quaternary ammonium ions can externally block voltage-gated K+ channels. Establishing a theoretical and experimental model that predicts KDs and the selectivity of K+ over Na+ ions","volume":"562","author":"Wempe","year":"2001","journal-title":"J. Mol. Struct."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","article-title":"MacKinnon R Cryo-EM Structure of the Open Human Ether-\u00e0-go-go-Related K+ Channel hERG","volume":"169","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"ref_3","unstructured":"(2022, September 05). Available online: https:\/\/www.chemicool.com\/definition\/quadrupole_mass_spectrometry.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/ed039p546","article-title":"Spectrometric identification of organic compounds","volume":"39","author":"Silverstein","year":"1962","journal-title":"J. Chem. Educ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fncel.2019.00358","article-title":"A Kinetic Map of the Homomeric Voltage-Gated Potassium Channel (Kv) Family","volume":"13","author":"Ranjan","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"a029231","DOI":"10.1101\/cshperspect.a029231","article-title":"Voltage-Gated Potassium Channels: A Structural Examination of Selectivity and Gating","volume":"8","author":"Kim","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_7","unstructured":"Kurachi, Y., Jan, Y., and Lazdunski, M. (1999). Potassium Ion Channels: Molecular Structure, Function, and Diseases, Elsevier. [1st ed.]."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1073\/pnas.91.8.3438","article-title":"A family of potassium channel genes related to eag in Drosophila and mammals","volume":"91","author":"Warmke","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02110698","article-title":"Molecular properties of voltage-gated K+ channels","volume":"28","author":"Dolly","year":"1996","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.280.5360.69","article-title":"The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity","volume":"280","author":"Doyle","year":"1998","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(99)02107-8","article-title":"Long QT syndromes and torsade de pointes","volume":"354","author":"Viskin","year":"1999","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cmdc.201100366","article-title":"Understanding of molecular substructures that contribute to hERG K+ channel blockade: Synthesis and biological evaluation of E-4031 analogues","volume":"7","author":"Vilums","year":"2011","journal-title":"ChemMedChem"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1021\/jm301564f","article-title":"Strategies to reduce hERG K+channel blockade. Exploring heteroaromaticity and rigidity in novel pyridine analogues of dofetilide","volume":"56","author":"Carvalho","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1021\/jm4010434","article-title":"Removal of human ether-\u00e0-go-go related gene (hERG) K+ channel affinity through rigidity: A case of clofilium Analogues","volume":"56","author":"Louvel","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/aps.2015.143","article-title":"Investigation of miscellaneous hERG inhigition in large diverse compound collection using automated patch-clamp assay","volume":"37","author":"Yu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1038\/s41598-019-53120-6","article-title":"Calculation of absolute binding free energies between the hERG channel and structurally diverse drugs","volume":"9","author":"Negami","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105390","DOI":"10.1016\/j.compbiomed.2022.105390","article-title":"Combining multi-dimensional molecular fingerprints to predict the hERG cardiotoxicity of compounds","volume":"144","author":"Ding","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphar.2019.01572","article-title":"An Update on the Structure of hERG","volume":"10","author":"Butler","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/ja01062a035","article-title":"p-\u03c3-\u03c0 Analysis. A Method for the Correlation of Biological Activity and Chemical Structure","volume":"86","author":"Hansch","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_22","unstructured":"Hammett, L.P. (1940). Physical Organic Chemistry, McGraw-Hill."},{"key":"ref_23","unstructured":"Humiston, B. (1986). General Chemistry, John Wiley & Sons, Inc.. [4th ed.]. Chapter 4."},{"key":"ref_24","unstructured":"Atkins, P.W. (1990). Physical Chemistry, W. H. Freeman and Company. [4th ed.]. Chapter 13."},{"key":"ref_25","unstructured":"Foresman, J.B., and Frisch, \u00c6. (1996). Exploring Chemistry with Electronic Structure Method, Gaussian, Inc.. [2nd ed.]."},{"key":"ref_26","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewski, V.G., Montgomery, J.A., Stratmann, R.E., and Burant, J.C. (1998). Gaussian 98W (Revision A.7), Gaussian, Inc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1359-6446(99)01383-5","article-title":"Cell-based assays and instrumentation for screening ion-channel targets","volume":"4","author":"Oades","year":"1999","journal-title":"Drug Discov. Today"},{"key":"ref_28","first-page":"1007","article-title":"Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-\u00e0-gogo K(+) channel","volume":"299","author":"Potet","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/mol.54.1.113","article-title":"Molecular basis for the lack of herg K+channel block-related cardiotoxicity by the h1receptor blocker cetirizine compared with other second-generation antihistamines","volume":"54","author":"Taglialatela","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1021\/jm0208875","article-title":"Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K+ Channel Blockers","volume":"45","author":"Cavalli","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.301.2.427","article-title":"Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium Channel","volume":"301","author":"Ekins","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/1439-7633(20020503)3:5<455::AID-CBIC455>3.0.CO;2-L","article-title":"A Virtual Screening Method for Prediction of the hERG Potassium Channel Liability of Compound Libraries","volume":"3","author":"Roche","year":"2002","journal-title":"ChemBioChem"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.300.2.543","article-title":"The Antidepressant Drug Fluoxetine Is an Inhibitor of Human Ether-A-Go-Go-Related Gene (HERG) Potassium Channels","volume":"300","author":"Thomas","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-291X(03)00980-X","article-title":"Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide","volume":"306","author":"Ridley","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.104.073692","article-title":"Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking","volume":"312","author":"Kuryshev","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/jpet.105.093393","article-title":"Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs","volume":"316","author":"Katchman","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.fjc.0000246853.15926.d4","article-title":"In vitro preclinical cardiac as-sessment of tolterodine and terodiline: Multiple factors predict the clinical experience","volume":"48","author":"Martin","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bcp.2007.04.024","article-title":"Inhi-bition of the HERG Potassium Channel by the Tricyclic Antidepressant Doxepin","volume":"74","author":"Duncan","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1254\/jphs.SC0070243","article-title":"The 5-HT(4) Agonists Cisapride, Mosapride, and CJ-033466, a Novel Potent Compound, Exhibit Different Human Ether-A-Go-Go-Related Gene (hERG)-blocking Activities","volume":"105","author":"Toga","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"ref_40","first-page":"525","article-title":"Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin","volume":"60","author":"Tu","year":"2008","journal-title":"Sheng Li Xue Bao"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.vascn.2007.10.004","article-title":"Evaluation of zebrafish embryos as a model for assessing inhi-bition of hERG","volume":"57","author":"Mittelstadt","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.phrs.2009.05.008","article-title":"H1 antihistamine drug promethazine directly blocks hERG K+ channel","volume":"60","author":"Jo","year":"2009","journal-title":"Pharmacol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/aps.2011.66","article-title":"Effects of the histamine H1 receptor antagonist hydroxyzine on hERG K+ channels and cardiac action potential duration","volume":"32","author":"Lee","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yjmcc.2011.09.021","article-title":"Molecular determinants of hERG potassium channel inhibition by disopyramide","volume":"52","author":"Zhang","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4196\/kjpp.2012.16.5.327","article-title":"Wide Spectrum of Inhibitory Effects of Sertraline on Cardiac Ion Channels","volume":"16","author":"Lee","year":"2012","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1254\/jphs.12117FP","article-title":"Effects of the antitussive drug cloperastine on ventricular repolarization in halothane-anesthetized guinea pigs","volume":"120","author":"Takahara","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1248\/bpb.b14-00244","article-title":"Blockade of HERG Human K+ Channels by the Antidepressant Drug Paroxetine","volume":"37","author":"Lee","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.01.048","article-title":"Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels","volume":"752","author":"Chae","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2015.06.021","article-title":"Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide","volume":"86","author":"Melgari","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2016.05.013","article-title":"Interactions between Amioda-rone and the hERG Potassium Channel Pore Determined With Mutagenesis and in Silico Docking","volume":"113","author":"Zhang","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2018.02.037","article-title":"The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT 4 receptor agonist, DSP-6952","volume":"826","author":"Tsubouchi","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/cea.13500","article-title":"Cardiac safety of second-generation H1-antihistamines when up-dosed in chronic spontaneous urticaria","volume":"49","author":"Cataldi","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/toxsci\/kfy299","article-title":"Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential","volume":"168","author":"Orvos","year":"2018","journal-title":"Toxicol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.273.33.21061","article-title":"HERG channel dysfunction in human long QT syndrome","volume":"273","author":"Zhou","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.59.1.122","article-title":"Interactions of a series of fluoroquinolone anti-bacterial drugs with the human cardiac K+ channel hERG","volume":"59","author":"Kang","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_56","first-page":"875","article-title":"Interaction of Terfenadine and Its Primary Metabolites with Cyto-chrome P450 2D6","volume":"26","author":"Jones","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.1993.03500120051025","article-title":"Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences","volume":"269","author":"Honig","year":"1993","journal-title":"JAMA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jphs.2019.12.007","article-title":"Utilization of the Chronic Atrioventricular Block Cynomolgus Monkey as an in Vivo Model to Evaluate Drug Interac-tion-Associated Torsade De Pointes","volume":"142","author":"Goto","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"H2534","DOI":"10.1152\/ajpheart.1997.273.5.H2534","article-title":"Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride","volume":"273","author":"Mohammad","year":"1997","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(97)01249-0","article-title":"A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity blockade of the human cardiac potassium channel HERG","volume":"417","author":"Rampe","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.97.2.204","article-title":"Block of the Rapid Component of the Delayed Rectifier Po-tassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval","volume":"97","author":"Drolet","year":"1998","journal-title":"Circulation"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:31:37Z","timestamp":1760142697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":61,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms231810732"],"URL":"https:\/\/doi.org\/10.3390\/ijms231810732","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}